Skip to content
HowShorted

MGP Ingredients, Inc. short interest in 2023

In 2023, MGP Ingredients, Inc.'s disclosed short interest ran from 10.37% of shares outstanding on 13 Jan 2023 to 13.48% on 29 Dec 2023, a change of +3.11 percentage points. The year's high was 13.61% on 15 Dec 2023 and its low 9.02% on 15 Jun 2023, averaging 10.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.65 days on 13 Oct 2023. Full history: MGP Ingredients, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MGP Ingredients, Inc. in 2023

2023 in figures

Start of year
10.37% (13 Jan 2023)
End of year
13.48% (29 Dec 2023)
Change
+3.11 pp
High
13.61% (15 Dec 2023)
Low
9.02% (15 Jun 2023)
Average
10.37%
Highest days to cover
29.65 (13 Oct 2023)
SEC filings marked
8

Every report in 2023

MGP Ingredients, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202310.37%22.27
31 Jan 202310.02%11.31
15 Feb 20239.83%19.28
28 Feb 20239.73%13.7610-K filed, results (8-K)
15 Mar 20239.71%21.09
31 Mar 202310.41%16.16
14 Apr 202310.61%20.04
28 Apr 202310.71%19.51
15 May 20239.83%20.9310-Q filed, results (8-K)
31 May 20239.65%18.07
15 Jun 20239.02%17.25
30 Jun 20239.07%12.51
14 Jul 20239.22%23.06
31 Jul 20239.21%28.72
15 Aug 20239.49%23.3710-Q filed, results (8-K)
31 Aug 20239.51%28.18
15 Sep 20239.66%21.87
29 Sep 202310.50%20.60
13 Oct 202310.50%29.65
31 Oct 202310.68%27.75
15 Nov 202311.70%20.6010-Q filed, results (8-K)
30 Nov 202312.40%18.83
15 Dec 202313.61%11.79
29 Dec 202313.48%28.37

See also: MGP Ingredients, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.